Everything you need to know about TMS and Medicare in 2026: What's Covered, What's Changed, and How to Avoid Denials — how it works, what it costs, and how to find a provider who actually knows what they're doing.

Medicare covers TMS therapy for depression. This has been true since 2014, and coverage has gotten meaningfully better over the past two years. If you are on Medicare and struggling with depression that has not responded to medication, TMS is a covered treatment option. In 2026, the path to getting it approved is smoother than it has ever been.

But covered does not mean automatically approved. Medicare’s TMS policies still have rules that trip people up. This guide covers what is actually covered, what changed this year, how to avoid denials, and what you will pay out of pocket.

What You’ll Learn

• What conditions Medicare covers TMS for in 2026
• Three specific policy changes that make Medicare TMS easier to access this year
• How to avoid common reasons for prior authorization denials
• What you will pay out of pocket with traditional Medicare vs. Medicare Advantage
• How to find Medicare-friendly TMS providers

What Medicare Covers Right Now

Major Depressive Disorder (MDD) is the primary covered indication. Medicare covers a course of TMS therapy, typically 36 sessions over six weeks, if you have MDD and have failed to respond to at least one adequate trial of antidepressant medication in the current episode.

The key phrase is adequate trial. Medicare generally defines this as at least 4-6 weeks at a therapeutic dose. If you tried sertraline for two weeks, felt lousy, and stopped, that likely will not count. Your treatment history needs to be clearly documented in your medical records.

Obsessive-Compulsive Disorder (OCD) gained Medicare coverage more recently. The FDA cleared deep TMS for OCD in 2018, and Medicare Administrative Contractors have progressively added coverage. As of 2026, most MACs cover TMS for OCD when you have failed adequate trials of both medication (typically an SRI at maximum tolerated dose for 8+ weeks) and cognitive behavioral therapy with exposure and response prevention.

Other conditions such as anxiety, PTSD, chronic pain, and substance use disorders are not yet covered by Medicare, even though some have FDA clearance. Off-label coverage decisions vary by MAC and are generally denied without extraordinary documentation.

What Changed in 2026

Three specific changes make this year notably better for Medicare beneficiaries seeking TMS.

Reduced Documentation Burden

Previously, many MACs required extensive pre-authorization documentation that could take weeks to compile. Detailed medication history going back years, letters from previous treating psychiatrists, psychological testing results, sometimes peer-to-peer review calls that delayed treatment by weeks.

The 2026 updates streamlined this. Most MACs now accept a standardized prior authorization form documenting the current depressive episode, at least one failed medication trial, a PHQ-9 score of 10 or higher, and a treatment plan from the ordering psychiatrist. The peer-to-peer requirement has been eliminated in several jurisdictions. Prior authorization decisions are now required within 7 business days in most regions.

This matters enormously in practice. Under the old system, you sometimes waited 4-6 weeks just for authorization, an eternity when you are severely depressed. The streamlined process typically takes 1-2 weeks.

Maintenance Session Coverage

This is the big one. Medicare has historically covered only the initial acute course of TMS (36 sessions). If your depression came back six months later, getting a second course approved was possible but often required starting the documentation process over from scratch, sometimes with additional medication trials demanded first.

The 2026 policy updates acknowledge what clinicians have long known. Some people need periodic maintenance TMS to sustain their remission. Several MACs now cover maintenance protocols, typically one to two sessions per month for up to six months following the acute course, with possible extension based on clinical response.

This is not universal yet. Coverage varies by MAC region, and you need to check with your specific plan. But the trajectory is clear, and the formal coverage determinations provide a framework for appeals even in regions that have not explicitly adopted maintenance coverage.

Theta Burst Stimulation Codes

Theta burst stimulation (TBS) has been FDA-cleared since 2018, but billing it through Medicare was awkward. Clinicians either used standard TMS codes (which did not reflect the shorter session time and sometimes triggered audits) or faced reimbursement uncertainty.

New CPT codes specific to theta burst stimulation took effect in 2026, providing clean billing pathways. This matters because TBS sessions take about 3 minutes compared to 19-37 minutes for conventional TMS. The per-session reimbursement is lower, reflecting the shorter treatment time, but the total cost for a full course is comparable and the administrative headaches have been resolved.

For you, this means you are more likely to be offered theta burst as an option. The practical benefit is shorter appointments, which is especially valuable if you have mobility or transportation challenges.

How to Avoid Denials

Even with improved policies, TMS denials happen. Here is how to minimize the risk.

Get your medication history documented before the prior auth submission. This is the number one reason for denials. Medicare wants clear evidence that you tried at least one antidepressant at an adequate dose for adequate duration. If your records are scattered across multiple providers, gather them. Ask previous prescribers for treatment summaries. Your TMS provider’s office can help with this, but do not assume they will track down records from a psychiatrist you saw three years ago.

Make sure your PHQ-9 score is current. A depression screening score from six months ago will not cut it. Your TMS provider should administer the PHQ-9 at the consultation visit, and that score should appear on the prior authorization.

Use a provider experienced with Medicare billing. Not all TMS clinics handle Medicare regularly, and the billing nuances matter. A clinic that primarily serves commercially insured people may not be up to speed on MAC-specific requirements. You can search our directory and filter for providers who accept Medicare.

Do not skip your sessions. Medicare can retroactively deny claims if you miss too many sessions, since it suggests the treatment was not medically necessary or you were not compliant. Life happens, but try to maintain the prescribed schedule. If you need to miss sessions, communicate proactively with your provider’s office so they can document the reason.

Know your appeal rights. If you are denied, you have the right to appeal. First-level appeals (redetermination) are decided within 60 days. The success rate on TMS appeals is actually quite good. Many initial denials are overturned when additional documentation is provided. Your TMS provider’s office should be willing to help with appeals. If they are not, consider a different provider.

What You Will Pay Out of Pocket

Medicare Part B covers TMS as an outpatient procedure. After you have met your annual Part B deductible ($257 in 2026), you are responsible for 20% coinsurance on the Medicare-approved amount.

For a standard 36-session TMS course, total Medicare-approved charges typically run $6,000-$12,000 depending on the protocol and your region. Your 20% share works out to roughly $1,200-$2,400.

If you have a Medicare Supplement (Medigap) plan, it may cover some or all of that 20% coinsurance. Plans C, D, F, and G typically cover Part B coinsurance in full. Check your specific plan.

Medicare Advantage (Part C) plans set their own cost-sharing rules. Some have lower coinsurance for TMS. Others have higher. Some require referrals or use narrower provider networks. Call your plan directly and ask about TMS cost-sharing before starting treatment.

The Medicare Advantage Wrinkle

This deserves its own section because it confuses a lot of people.

If you have a Medicare Advantage plan (from UnitedHealthcare, Humana, Aetna, and others), your TMS coverage is governed by your plan’s specific policies, not traditional Medicare’s. Most MA plans follow CMS guidelines, but they can impose additional requirements: prior authorization procedures, network restrictions, step therapy protocols, or different cost-sharing amounts.

The practical upside: some MA plans have lower out-of-pocket costs than traditional Medicare for TMS. The practical downside: some have more restrictive authorization requirements, and the appeal process can be more cumbersome.

Always verify coverage with your specific MA plan before starting treatment. Get the authorization in writing. And make sure your TMS provider is in-network. Out-of-network TMS with a Medicare Advantage plan can mean paying the full cost yourself.

Finding a Medicare-Friendly TMS Provider

Not every TMS clinic accepts Medicare. The reimbursement rates are lower than commercial insurance, and some smaller practices have opted out. Before you get emotionally invested in a particular clinic, confirm that they are a participating Medicare provider.

Search our provider directory to find TMS clinics in your area that accept Medicare. You can also call your local MAC (Medicare Administrative Contractor) for a list of participating TMS providers in your region.

Once you have identified a provider, ask these specific questions at your consultation:

• Do you accept Medicare assignment?
• Will you handle the prior authorization?
• How many Medicare TMS patients have you treated?
• What is your denial rate, and do you help with appeals?
• Do you offer theta burst stimulation?

A clinic that confidently answers all of these has likely been through the Medicare TMS process many times before. That experience translates directly into a smoother process for you.